Urinalysis Market Growth & Trends
The global urinalysis market size is expected to reach USD 5.4 billion by 2030, according to a new study by Grand View Research Inc. The market is expected to witness a CAGR of 4.6% from 2022 to 2030. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms referable to the Gastrointestinal Tract (GU).
Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis; hence, it is anticipated to drive market growth.
Moreover, for patients undergoing transplant surgeries including kidney and liver, transplant procedures is often recommended to undergo preoperative urinalysis to avoid urinary tract infections (UTIs). According to United Network for Organ Sharing data, around 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants were performed in the U.S. in 2021. Thus, an increasing number of transplant surgeries is expected to fuel market growth.
Companies are taking initiatives such as collaboration and strategic partnerships for the development and marketing of technologically advanced urinalysis products. For instance, in October 2021, Sysmex entered into collaboration with Inpeco for the development of an automated urinalysis workflow solution of the highest level. This product was developed with a help of UN-Series of Sysmex’s and FlexLab TM track of Inpeco’s urinalysis solutions. It is the only fully open automation system that helps laboratories optimize their workflow support and provide premium patient care.
Request a free sample copy or view report summary:
Urinalysis Market Report
Report Attribute Details
Market size value in 2022 — USD 3,776.9 million
Revenue forecast in 2030 — USD 5.4 billion
Growth rate — CAGR of 4.6% from 2022 to 2030
Base year for estimation — 2021
Historical data — 2018–2020
Forecast period — 2022–2030
Urinalysis Market Report Highlights
- Based on product, the consumables segment held the largest share market in 2021 due to wider usage of dipsticks due to their efficiency coupled with lost costs
- Based on application, the disease screening segment accounted for the largest segment, owing to the increasing prevalence of target diseases such as UTI, kidney disease, and liver disease, along with the rising application of urinalysis for screening of these diseases
- On the basis of end-use, the clinical laboratories segment dominated the market in 2021 owing to higher patient footfall in clinical laboratories for urine testing for disease diagnosis
- Home care segment is expected to witness significant growth over the forecast period owing to increasing investment for the development of home-based urine testing kits for disease diagnosis
- North America segment dominated the market in 2021 due to favorable reimbursement policies, rising incidence of UTI, well-established healthcare infrastructure, and supportive regulatory reforms
